Symphony other research news

The Malvern, Penn., company received a three-year, $1.7 million Advanced Technology Program grant from the National Institute of Standards and Technology to develop a technology to identify compounds that modulate RBP/RNA interactions as a means of treating diseases. The technology is based on the regulation of protein expression at the post-transcriptional level through the modulation of RBP/RNA interactions. ...